Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

29-Sep-2006

  • Alternative Medicine: Saw palmetto for prostate health (Seattle Post-Intelligencer)

    Saw palmetto is a well-established herbal treatment for men who have symptoms of an enlarged prostate, known as benign prostatic hyperplasia (BPH).


  • The Relationship Of Ultrasensitive Measurements Of Prostate-specific Antigen Levels To Prostate Cancer Recurrence After (Medical News Today)

    A rising PSA following radical prostatectomy (RP) for prostate cancer (CaP) suggests disease recurrence. Ultrasensitive PSA (USPSA) tests can detect PSA at values as low as 0.001ng/ml. Dr. Taylor and colleagues publish a report in the September 2006 issue of the BJU International that evaluates USPSA values in the context of clinical outcomes. [click link for full article]


  • Long-term Outcomes For Prostate Cancer Show Intensity Modulated Radiation Therapy Curative (Science Daily)

    Results from the largest study of men with prostate cancer treated with high-dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease after an average follow-up period of eight years.


  • Prostate Cancer Appears Cured in 89 Percent of Men Treated with IMRT (Senior Journal)

    September 27, 2006 - The vast majority of prostate cancer victims ? 89 percent - treated with high-dose, intensity modulated radiation therapy (IMRT) are alive and show no evidence of the cancer eight years after the treatment.


  • Sensitive And Specific Biomarker For Early Detection Of Prostate Cancer Identified (Science Daily)

    Scientists at a Maryland-based pharmaceutical company have preliminary evidence showing that a protein in the blood may prove to be a biomarker that is more sensitive and specific than current methods of early detection for prostate cancer.


  • Published Study Shows Focal Cryoablation Effective in Destroying Prostate Cancer, Preserving Potency, Continence (PR Newswire via Yahoo! Finance)

    Endocare, Inc. , an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, announced today that a new study has demonstrated that specially targeted cryoablation, known as "focal cryoablation," may effectively destroy cancerous tumors in the prostate while preserving a patient's potency and continence.


  • Prostate cancer screening event was a success (The Kentucky Standard)

    The University of Louisville Kentucky Cancer Program (KCP) is grateful to Nelson County-City of Bardstown for helping to make the recent free prostate cancer screening, Drive Across Kentucky, a huge success.


  • Hospital to host prostate cancer seminar (Asbury Park Press)

    A seminar on prostate cancer will be held Thursday at 5 p.m. at the Ocean Medical Center on Jack Martin Boulevard. The free seminar, "Life After prostate Symposium,'' will include presentations from doctors and prostate cancer survivors. The session ends with a question-and-answer session. The seminar will be held at the hospital's east wing conference center. To register, call (800) 560-9990


  • Back to Prostate News Archive